Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Olivia P. Carter

30 indexed publications match this author name.

ORCID: 0000-0001-7708-6154
OpenAlex: https://openalex.org/A5049486527

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Receptor Pharmacology 13 Safety 11 Clinical Trial 9 Chronic Pain 8 Toxicity 7 Depression 6 Review Article 6 Randomized Controlled Trial 5 Observational Study 5 Adverse Events 5 Healthy Volunteers 5 Consciousness 5

Journals

Research Square 2 Journal of Vision 2 Queensland's institutional digital repository (The University of Queensland) 2 Neurology 1 Journal of Analytical Toxicology 1 Progress in Neuro-Psychopharmacology and Biological Psychiatry 1 Brain and Behavior 1 medRxiv 1

Publication history

Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)Neurology · 2026-06-08 Prolonged Grief Symptom Outcomes During At-Home Ketamine-Assisted Therapy: A Real-World Retrospective Analysis of 503 AdultsResearch Square · 2026-06-01 Studies on enzymatic hydrolysis of psilocin- O -glucuronide for screening of psilocin in human urine by liquid chromatography-triple quadrupole tandem mass spectrometryJournal of Analytical Toxicology · 2026-05-26 Psilocybin’s Kinematic Effect on Manual DexterityResearch Square · 2026-04-14 Psychedelics in functional disorders: A scoping reviewProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2026-02-09 Participant Experiences of Therapeutic Touch in Psilocybin-Assisted TherapyBrain and Behavior · 2026-01-31 A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy ParticipantsmedRxiv · 2025-12-22 Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot studyActa Neuropsychiatrica · 2025-11-03 Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trialTherapeutic Advances in Psychopharmacology · 2025-08-31 The ethical use of therapeutic touch in psychedelic-assisted therapy: a qualitative study of researcher perspectives and experiences.Therapeutic advances in psychopharmacology · 2024-12-31 ALSUntangled #77: Psilocybin.Unknown journal · 2024-12-21 Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy ParticipantsPsychiatric Research and Clinical Practice · 2024-07-22 Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc AnalysisNeuropsychiatric Disease and Treatment · 2023-09-30 Perceptions of psychedelic-assisted therapy among Black AmericansJournal of Mood and Anxiety Disorders · 2023-09-25 Beliefs and Perceived Barriers Regarding Psychedelic-assisted Therapy in a Pilot Study of Service Members and Veterans With a History of Traumatic Brain InjuryMilitary Medicine · 2022-12-23 Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.BMJ Open · 2021-11-30 Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.Australian & New Zealand Journal of Psychiatry · 2021-03-20 Psychedelic-assisted therapies: The past, and the need to move forward responsiblyInternational Journal of Drug Policy · 2019-05-24 Dimensions of consciousness and the psychedelic state.Neuroscience of Consciousness · 2018-09-18 High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.Unknown journal · 2012-04-12 The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.Biological Psychiatry · 2010-12-02 Psilocybin slows binocular rivalry switching through serotonin modulationJournal of Vision · 2010-03-18 Using psilocybin to investigate the relationship between attention, working memory and the serotonin 5-HT1A and 5-HT2A receptorsJournal of Vision · 2010-03-16 Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.Psychopharmacology · 2007-09-13 Effects of psilocybin on time perception and temporal control of behaviour in humans.Queensland's institutional digital repository (The University of Queensland) · 2006-05-18 Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors.Journal of Cognitive Neuroscience · 2005-09-30 Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin.Unknown journal · 2005-05-31 Psilocybin impairs high-level but not low-level motion perception.Unknown journal · 2004-07-31 The Effects of he Hallucinogenic Serotonin 1A/2A Agonist, Psilocybin, on Binocular Rivalry and Visual Contrast Detection ThresholdsQueensland's institutional digital repository (The University of Queensland) · 2003-12-31 A double-blind, placebo controlled study of the effect of the hallucinogenic 5-HT1A&2A agonist psilocybin on binocular rivalry rate and rhythmicitySocial Neuroscience · 2002-12-31

Author directory